Johnson & Johnson
Recent News About Johnson & Johnson View More
-
Ethicon doctor says 20 percent erosion rate okay, sales manager says company reps honest
SAN DIEGO – On Thursday, a doctor for Ethicon, a subsidiary for Johnson & Johnson, said he thought a 20 percent erosion rate for women was acceptable, while a company sales manager said sales reps had been honest about the risks of the company's pelvic mesh devices. -
J&J opposes Prop 65 talc case dismissal, accuses plaintiffs' attorney of 'transparent tactical maneuver'
LOS ANGELES – A federal judge is expected to hear arguments next week over a motion by counsel for a group of plaintiffs in a personal Injury and product liability case against Johnson & Johnson, asking that their lawsuit be dismissed. -
During trial over vaginal mesh, Ethicon sales manager says reps not pushy
SAN DIEGO – A sales manager for Ethicon, the producer of vaginal mesh implants for women, on Wednesday told attorneys for the California attorney general that company sales reps were not pushy in selling the devices, but proceeded only if they sensed an unmet need. -
Marketing expert insists J&J pelvic mesh promotional material misleads consumers
SAN DIEGO – A marketing expert on Tuesday in a trial to determine if Johnson & Johnson sold injury-causing pelvic mesh implants to women by ignoring the dangers and through deceptive sales tactics continued to insist to J&J lawyers the company had downplayed the risks to make sales. -
Marketing expert testifies for state: J&J minimizes mesh implant risk in selling
SAN DIEGO – A marketing expert serving as a witness for state attorneys on Monday said Johnson & Johnson had downplayed the risks of its pelvic mesh implants to sell the devices to women in a trial to decide if the company put profits before safety. -
Roundup, talc cases force question: What if juries get the science wrong?
SAN FRANCISCO – On one coast, Bayer AG is fighting to reverse eye-popping jury verdicts based on a contested theory Roundup herbicide made by its Monsanto unit causes cancer. On the other, Johnson & Johnson begins hearings this week in federal court in New Jersey over its request to exclude more than 20 expert witnesses plaintiff lawyers need to prove their case that Johnson’s Baby Powder is contaminated with deadly asbestos and can cause ovarian cancer. -
State’s witness portrayed as professional testifying millionaire in pelvic mesh case
SAN DIEGO – The lawyer for Johnson & Johnson on Thursday sought to portray an expert witness for the state as a highly paid plaintiff testifier in a trial over allegations the company sold dangerous bladder sling devices that injured women and falsely minimized the risks. -
Doctor says mesh can disfigure, causing women acute pain in J&J trial
SAN DIEGO – During a second day of testimony on Wednesday in California's case against Johnson & Johnson over a pelvic mesh device, Dr. Bruce A. Rosenzweig, a gynecologist and urinary tract specialist with the Rush University Medical Center in Chicago, described for the court what happens when pelvic mesh inside a woman’s body deforms. -
In AG's mesh suit, woman describes pelvic pain, but J&J points to 'Success Story' plaintiff wrote to doc
SAN DIEGO – A San Diego County woman recalled her suffering after a vaginal mesh implant was performed and a doctor said the mesh sometimes appears deformed upon removal in a trial accusing Johnson & Johnson and its subsidiary Ethicon of offering defective injury-causing incontinence devices. -
Trial opens in California in case accusing Johnson & Johnson of pelvic mesh injuries
SAN DIEGO – Trial opened Monday in a lawsuit filed by California Attorney General Xavier Becerra accusing Johnson & Johnson and its pelvic mesh device called “Prolift” made by a subsidiary Ethicon of causing vaginal injuries in women and said the company had engaged in deceptive marketing practices. -
Jury finds J&J and Colgate-Palmolive liable for $12 million in woman’s mesothelioma suit
OAKLAND – A jury on Wednesday awarded plaintiff Patricia Schmitz $12 million in damages agreeing that Johnson & Johnson baby powder and a face powder product from Colgate-Palmolive called Cashmere Bouquet contaminated with asbestos had caused her mesothelioma. -
Jury awards plaintiff in case against J&J, Colgate Palmolive $12 million
OAKLAND - A jury has awarded a 61-year-old woman $12 million in damages in a verdict against Johnson & Johnson and Colgate Palmolive announced Wednesday. -
Closing arguments heard in Schmitz mesothelioma trial, J&J lawyers argue disease was spontaneous
OAKLAND – Closing arguments were heard Monday in a trial over allegations that Johnson & Johnson baby powder and a face powder product called Cashmere Bouquet produced by Colgate-Palmolive caused a woman’s mesothelioma. -
Plaintiff lawyer casts mineralogist witness for Johnson & Johnson as talc industry mouthpiece
OAKLAND – Plaintiff attorneys on Wednesday sought to portray a mineralogist expert witness for Johnson & Johnson as a paid professional hireling of the talc industry in a trial of a case alleging the company’s baby powder caused a woman’s mesothelioma. -
Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on
NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman. -
Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial
NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit. -
Mineralogist called by defendants in Schmitz trial says no asbestos in J&J baby powder
OAKLAND – A mineralogist called by attorneys defending Johnson & Johnson said on Tuesday there was no asbestos found in the baby powder he tested from talc mines in Italy and Vermont. -
Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement
NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed. -
Johnson & Johnson witness says he did not act not 'ruthless' regarding talc powder
OAKLAND – A top witness for Johnson & Johnson in a trial in which the company is accused of causing a woman’s mesothelioma along with Colgate-Palmolive on Wednesday denied the company had behaved badly in defending the use of talc powder. -
Industrial hygienist says talc powder low risk while plaintiff attorney differs in J&J trial
ALAMEDA – An industrial hygienist called as a witness for attorneys defending Johnson & Johnson and Colegate-Palmolive on Wednesday told a jury Patricia Schmitz’s exposure to asbestos was no more than background level.